Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection. Con D, Van Langenberg DR, Vasudevan A. Clin Gastroenterol Hepatol 2021;19:1077.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Con D, Van Langenberg DR, Vasudevan A. Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection. Clin Gastroenterol Hepatol 2021;19:1077.
PMID: 33249017